FREE Case Review (866) 588-0600

Actos® Heart Attack Information

Actos has recently come under serious scrutiny by the FDA, health experts, and consumer advocates because of the significantly increased risk of heart-related side effects.

Actos Bladder Cancer Lawsuit Update 8/2/12: Last month, a class action lawsuit was filed in Quebec, Canada on behalf of individuals who were diagnosed with bladder cancer after taking Actos. This is at least the second class action filed over Actos bladder cancer in Canada, after a similar claim was filed in Ontario last December. Click here to learn more.

Actos Bladder Cancer Lawsuit Update 7/17/12: According to an order issued earlier this week, it will be more than two years before the first federal Actos bladder cancer lawsuits go to trial. Last December, the Actos multidistrict litigation (MDL) was centralized before U.S. District Judge Rebecca Doherty in the Western District of Louisiana for consolidated handling during pretrial proceedings. Click here</> to learn more.

Actos Bladder Cancer Lawsuit Update 6/14/12: If Takeda Pharmaceuticals’ attorneys have their way, patients diagnosed with bladder cancer after using Actos will face a deadline for filing their lawsuit tomorrow, if the drug was prescribed or taken in a state with a one-year statute of limitations. June 15, 2012, marks exactly one year after the U.S. Food & Drug Administration (FDA) issued a warning about the possible link between Actos and bladder cancer. Click here to learn more.

Free Actos Heart Attack Case Evaluation: If you or a loved one has suffered a heart attack or other serious side effect as a result of taking Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

What’s the problem?

Avandia has long been surrounded with debate concerning cardiovascular risks, while Actos was believed a safer alternative, causing sales of Actos to increase and Avandia seeing significant declines. Both drugs are members of the family known as thiazolidinediones, which decrease the insulin resistance of body tissues and modify the production of cholesterol. They are considered among the most powerful drugs for treating type 2 diabetes but have been plagued by reports of side effects. Emerging research seems to suggest that similar heart risks are being seen in both drugs.

New Actos Heart Attack Study

In a new study reported in August 2010, a team led by Debra Wertz, an outcomes research manager at HealthCore, the research subsidiary of the health insurance company WellPoint, studied the records of 28,938 clients who took either Actos or Avandia from 2001 to 2005. They reported in the journal Circulation: Cardiovascular Quality and Outcomes that, when they accounted for potential confounding effects – including age, gender and prior heart disease – about 4 percent of each group had a heart attack, heart failure, or died.

Are you taking Actos?

Patients who develop symptoms of Actos-related heart failure, heart attack, or other side effects should immediately contact their health care provider. Such symptoms may include an unusually rapid increase or decrease in weight, fluid retention (edema), shortness of breath, unexplainable fatigue and weakness, confusion and fatigue, and chest pain.

Particularly in the case of heart attack, the symptoms of heart failure can develop rapidly. In most cases, however, the symptoms of heart disease develop over days or even months. Any unusual symptoms that develop while taking Actos should be discussed with your doctor as soon as possible.

Do I have an Actos Heart Attack Lawsuit?

The Defective Drug & Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Actos heart attack lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition